The cGAS – STING Pathway Drives Astrocyte‐Mediated Demyelination in Multiple Sclerosis Through Clusterin Secretion
CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)
DOI: 10.1002/cns.71091 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 14.08.2026. Verfasst von Shengfei Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Astrocytes, Multiple Sclerosis, Membrane Proteins, Clusterin. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) is a chronic neuroinflammatory disorder characterized by oligodendrocyte injury and demyelination. The disease progresses from peripheral immune attacks to compartmentalized central nervous system (CNS) inflammation, culminating in irreversible neurodegeneration. Although current immunotherapies suppress peripheral relapses, they inadequately address compartmentalized CNS inflammation and progressive neurodegeneration.
Methods
We reanalyzed published single‐nucleus RNA‐seq datasets from human MS lesions. Primary astrocytes, oligodendrocytes, and organotypic cultures were used for in vitro studies. Outcomes were assessed by immunofluorescence, Western blot, qRT‐PCR, RNA‐seq, cell viability assay, and behavioral scoring. The STING inhibitor H‐151 was administered in preventive and therapeutic paradigms.
Results
Single‐nucleus RNA‐seq showed inflammatory astrocytes accumulate preferentially at chronic active lesion edges in MS. These astrocytes exhibited STING pathway activation, coinciding with elevated DNA concentrations in cerebrospinal fluid. Mechanistically, DNA synergized with pro‐inflammatory cytokines to trigger astrocytic STING signaling, driving Clusterin (CLU) secretion that directly induced oligodendrocyte apoptosis and demyelination. Pharmacological inhibition of STING with H‐151 prevented and ameliorated established clinical deficits in experimental autoimmune encephalomyelitis mice.
Conclusion
DNA elevation in inflammatory microenvironments activates the astrocytic STING–CLU axis to promote disease pathogenesis, validating STING targeting as a treatment strategy for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- The Center of Mental and Neurological Disorders Study, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Yiying Huang, Hanzhang Tan, Wei Qiu, Rui Li
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Hu, S., Xiao, X., Cheng, X., Huang, Y., Cui, T., Shen, S., Cui, C., Xiao, L., Tan, H., Qiu, W., Zhao, Y., & Li, R. (2026). The cGAS – STING Pathway Drives Astrocyte‐Mediated Demyelination in Multiple Sclerosis Through Clusterin Secretion. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71091
Vancouver
Hu S, Xiao X, Cheng X, Huang Y, Cui T, Shen S, et al. The cGAS – STING Pathway Drives Astrocyte‐Mediated Demyelination in Multiple Sclerosis Through Clusterin Secretion. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71091
BibTeX
@article{Hu2026,
author = {Hu, Shengfei and Xiao, Xia and Cheng, Xi and Huang, Yiying and Cui, Tingting and Shen, Shishi and Cui, Chunping and Xiao, Li and Tan, Hanzhang and Qiu, Wei and Zhao, Yipeng and Li, Rui},
title = {The cGAS – STING Pathway Drives Astrocyte‐Mediated Demyelination in Multiple Sclerosis Through Clusterin Secretion},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {8},
doi = {10.1002/cns.71091}
}
EUVIMED